Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Cigna

(

CI

) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 1.2%. By the end of trading, Cigna rose $1.92 (2.5%) to $79.41 on average volume. Throughout the day, 2,527,113 shares of Cigna exchanged hands as compared to its average daily volume of 2,066,200 shares. The stock ranged in a price between $77.89-$79.55 after having opened the day at $78.07 as compared to the previous trading day's close of $77.49. Other companies within the Health Care sector that increased today were:

Idera Pharmaceuticals

(

IDRA

), up 17.8%,

Trevena

(

TRVN

), up 11.4%,

Actinium Pharmaceuticals

(

ATNM

), up 9.0% and

CytRx Corporation

(

CYTR

), up 7.9%.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $21.7 billion and is part of the health services industry. Shares are down 11.4% year to date as of the close of trading on Thursday. Currently there are 8 analysts that rate Cigna a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates

Cigna

as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front,

LipoScience

(

LPDX

), down 19.6%,

Conatus Pharmaceuticals

(

CNAT

), down 15.6%,

Tekmira Pharmaceuticals Corporation

(

TKMR

), down 14.5% and

Spherix

(

SPEX

), down 12.5% , were all laggards within the health care sector with

AbbVie

(

ABBV

) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.